Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.530
+0.070 (4.79%)
Feb 19, 2026, 4:00 PM EST - Market closed
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $199.18 million as of February 19, 2026. Its market cap has increased by 324.70% in one year.
Market Cap
199.18M
Enterprise Value
182.13M
1-Year Change
324.70%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $199.18M, a decrease of -33.91%. That is a compound annual growth rate of -4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 104.00M | -10.42% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 194.93M |
| Tonix Pharmaceuticals Holding | 193.70M |
| Voyager Therapeutics | 188.48M |
| Sol-Gel Technologies | 187.20M |
| Prelude Therapeutics | 183.75M |
| SAB Biotherapeutics | 183.29M |
| C4 Therapeutics | 183.17M |
| Galectin Therapeutics | 177.94M |